Cellular Therapies & Biotherapies

Cellular therapies and biotherapies are growing areas of medicine that are transforming patient care. AABB works with the cellular therapies community to drive policies that ensure patient access, advance research, increase the supply and safety biological products, and expand coverage for these transformative therapies.

Policy Priorities

  1. Support patients’ access to safe, medically appropriate cellular therapies. Cellular therapies are constantly evolving, innovative therapies that originate as human cells and are transplanted or infused to replace or repair damaged tissue or cells.
  2. Encourage research related to cellular therapies.
  3. Advance a sustainable supply of high-quality cord blood products.